Zimmer Biomet Holdings Inc has entered into an underwriting agreement for a public offering of $600 million in 4.700% notes due 2027, $550 million in 5.050% notes due 2030, and $600 million in 5.500% notes due 2035, with the sale expected to close on February 19, 2025.